Aufrufe
vor 5 Monaten

Leseprobe CONNEXIPLUS 2021-1 COVID-19 und Impfstoffe

  • Text
  • Nustendi
  • Novartis
  • Leqvio
  • Inclisiran
  • Vazkepa
  • Bempedoinsaeure
  • Covid
  • Hoxha
  • Cov
  • Covid
  • Ruediger
  • Mueller
  • Langer
  • Laufs
  • Plettenberg
  • Synlab
  • Maerz
  • Pandemie
  • Impfstoffe
  • Connexiplus
Fachmagazin zu COVID-19

VIRUSNACHWEIS

VIRUSNACHWEIS connexiplus 11. To KKW, Tsang OTY, Yip CCY et al. Consistent detection of 2019 novel coronavirus in saliva. Clin Infect Dis 2020; 71: 841–3. 12. Williams E, Bond K, Zhang B et al. Saliva as a noninvasive specimen for detection of sars-cov-2. J Clin Microbiol 2020; 58: 1–2. 13. Rao M, Rashid FA, Sabri FSAH et al. Comparing nasopharyngeal swab and early morning saliva for the identification of SARS-CoV-2. Clin Infect Dis 2020 Aug 6: ciaa 1156. Online ahead of print. 14. Wyllie AL, Fournier J, Casanovas-Massana A et al. Saliva or nasopharyngeal swab specimens for detection of SARS- CoV-2. N Engl J Med 2020; 383:1283–6. 15. Guo W-L, Jiang Q, Ye F et al. Effect of throat washings on detection of 2019 novel coronavirus. Clin Infect Dis 2020; 71:1980–1. 16. Malecki M, Lüsebrink J, Teves S, Wendel AF. Pharynx gargle samples are suitable for SARS-CoV-2 diagnostic and save personal protective equipment and swabs. Infect Control Hosp Epidemiol 2021; 42(2): 248–9. 17. Saito M, Adachi E, Yamayoshi S et al. Gargle lavage as a safe and sensitive alternative to swab samples to diagnose COVID-19: a case report in Japan. Clin Infect Dis 2020; 71: 893–4. 18. Corman VM, Landt O, Kaiser M et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill 2020; 25(3): 2000045. 19. Kanji JN, Zelyas N, MacDonald C et al. False negative rate of COVID-19 PCR testing: a discordant testing analysis. Virol J 2021; 18: 1–6. 20. RKI. Verfügbar unter: https://www.rki.de/DE/Content/ InfAZ/N/Neuartiges_Coronavirus/Vorl_Testung_nCoV. html [letzer Zugriff 28.3.2021]. 21. He X, Lau EHY, Wu P et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat Med 2020; 26: 672–5. 22. Schildgen V, Demuth S, Lüsebrink J, Schildgen O. Limits and opportunities of SARS-CoV-2 antigen rapid tests: an experienced-based perspective. Pathog (Basel, Switzerland) 2021; 10: 1–7. 23. Kohmer N, Toptan T, Pallas C et al. The comparative clinical performance of four SARS-CoV-2 rapid antigen tests and their correlation to infectivity in vitro. J Clin Med 2021; 10(2): 328. 24. Prince-Guerra JL, Almendares O, Nolen LD et al. Evaluation of Abbott BinaxNOW Rapid Antigen Test for SARS-CoV-2 infection at two community-based testing sites – Pima County, Arizona, November 3–17, 2020. MMWR Morb Mortal Wkly Rep 2021; 70: 100–5. 25. Mak GC, Lau SS, Wong KK et al. Analytical sensitivity and clinical sensitivity of the three rapid antigen detection kits for detection of SARS-CoV-2 virus. J Clin Virol 2020; 133: 337–9. 26. Niko Kohmer, Holger F. Rabenau SC. Der richtige Nachweis. Dtsch Aerzteblatt Int 2020; 17: 866–71. 27. IMD Institut für Medizinische Diagnostik Berlin-Potsdam GbR Indikation und Interpretation der SARS-CoV-2-Antikörperdiagnostik. Verfügbar unter: https://www.imd-berlin.de/fachinformationen/diagnostikinformationen/indikation-und-interpretation-der-sars-cov-2-antikoerperdiagnostik.html [Letzter Zugriff 25.03.2021]. 28. RKI. Verfügbar unter: https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Projekte_RKI/ SeBluCo_Zwischenbericht [Letzter Zugriff 29.03.2021]. 29. Wiersinga WJ, Rhodes A, Cheng AC et al. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA 2020; 324: 782–93. 30. Zhao J, Yuan Q, Wang H et al. Antibody responses to SARS-CoV-2 in patients with novel coronavirus disease 2019. Clin Infect Dis 2020; 71: 2027–34. 31. Sun B, Feng Y, Mo X et al. Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients. Emerg Microbes Infect 2020; 9: 940–8. 32. A-z SI. Übersicht und Empfehlungen zu besorgniserregenden SARS-CoV-2-Virusvarianten (VOC) Situation in Deutschland Molekulare Surveillance in Deutschland. 2021: 24–6. 33. RKI. Verfügbar unter: https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/DESH/Bericht_ VOC_2021-03-24.pdf?__blob=publicationFile [Letzter Zugriff 28.03.2021]. Dr. med. Martin Roskos Dr. rer. nat. Caroline Pfeifer Univ. Prof. Dr. med. Winfried März synlab Akademie, Synlab Holding Deutschland GmbH, P5 7, 68167 Mannheim 62

Visualize Your Science. Medical and Scientific Animations Mechanism of Action Videos VR and AR Interactives Web - Conferences - Presentations - Apps www.NewtStudios.com

Connexi - Leseproben